作者：
Hargrave,D. [1]
;
Geoerger,B. [2]
;
Frappaz,D. [3]
;
Pietsch,T. [4]
;
Gesner,L. [5]
;
Cisar,L. [6]
;
Breazna,A. [7]
;
Dorman,A. [8]
;
Cruz-Martinez,O. [9]
;
Fuster,J.L. [10]
;
Rialland,X. [11]
;
Icher,C. [12]
;
Leblond,P. [13]
;
Ashley,D. [14]
;
Perilongo,G. [15]
;
Elliott,M. [16]
;
English,M. ;
Clausen,N. ;
Grill,J.
作者单位：
Servicios de Pediatría, Unidad Integrada Hospital Sant Joan de Déu-Clínic, Universidad de Barcelona
[1]
Department of Paediatrics, University of Padua, Padua, Italy
[2]
Institut d'Hémato-Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France
[3]
Centre Oscar-Lambret, Unité d'Oncologie Pédiatrique, Lille, France
[4]
Paediatric Oncology, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom
[5]
Groupe Hospitalier Pellegrin, H?pital Pellegrin CHU Bordeaux, Bordeaux, France
[6]
Pathology Services, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
[7]
Department of Neuropathology, University of Bonn Medical Center, Bonn, Germany
[8]
Paediatric Oncology Unit, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
[9]
Department of Paediatric Hematology and Oncology, Leeds General Infirmary, Leeds, United Kingdom
[10]
Department of Radiology, St. Barnabas Medical Center, Livingston, United States
[11]
Pfizer Inc., New York, United States
[12]
Centre Robert Debré CHU Angers, Angers, France
[13]
Department of Paediatrics, University Hospital of Aarhus at Skejby, Aarhus, Denmark
[14]
Andrew Love Cancer Centre, Geelong Hospital, Deakin University, Geelong, Australia
[15]
Department of Paediatric and Adolescent Oncology, University Paris-Sud XI, Institut Gustave Roussy
[16]
发布时间
2013-11-20
换一批
